Yki-Järvinen H, Taskinen M R, Kiviluoto T, Hilden H, Helve E, Koivisto V A, Nikkilä E A
J Clin Endocrinol Metab. 1984 Dec;59(6):1183-92. doi: 10.1210/jcem-59-6-1183.
To evaluate the mechanism of insulin resistance in type 1 diabetes mellitus, we measured insulin sensitivity in vivo and insulin action in adipocytes in vitro. The study groups consisted of 18 insulin-treated type 1 diabetic patients and 14 matched normal subjects. In each subject, insulin-mediated glucose disposal in vivo was measured by the euglycemic clamp technique. An open surgical biopsy was performed in 9 diabetic and 7 healthy subjects to obtain abdominal sc adipose tissue for the measurement of [125I]insulin binding, D-[14C]-glucose transport, oxidation, and lipogenesis. During the euglycemic clamp studies, similar steady state plasma glucose (4.8 mmol/liter) and insulin (80 mU/liter = 700 pM) levels were maintained in both groups. The rate of glucose metabolism (M) was 43% lower in the diabetic patients (4.75 +/- 0.34 mg/kg X min) than in the normal subjects (8.27 +/- 0.43 mg/kg X min; P less than 0.001). [125I]Insulin binding to adipocytes was reduced in the diabetic patients (26% reduction in tracer binding; P less than 0.05) due to a reduction in receptor number. Insulin binding was not related to the M value at any insulin concentration. Basal and insulin-stimulated rates of glucose transport were not significantly different in diabetic and normal subjects. The basal glucose oxidation rate was reduced by 50% (P less than 0.02), and maximal glucose oxidation was reduced by 49% (P less than 0.03) in the diabetic patients (237 +/- 30 vs. 359 +/- 49 pmol/30,000 cells X 90 min, basal vs. maximal glucose oxidation, respectively) compared to those in normal subjects (513 +/- 101 vs. 700 +/- 133 pmol/30,000 cells X 90 min). The percentage responses of glucose oxidation and glucose transport to insulin were similar in both groups. Glucose oxidation rates at basal (r = 0.68; P less than 0.01), half-maximally (ED50; r = 0.70; P less than 0.01), and maximally (r = 0.64; P less than 0.05) effective insulin concentrations were positively related to the M value. Basal and insulin-stimulated rates of lipogenesis were comparable between the diabetic and normal subjects. In conclusion, insulin-mediated glucose disposal in vivo is reduced in conventionally treated type 1 diabetic patients. In vitro, adipocytes from diabetes bound slightly less insulin at tracer insulin concentrations, but the magnitude of this reduction was not related to impairment of glucose metabolism in vivo. Of the pathways of glucose metabolism studied, the rate of glucose oxidation was most affected. A significant relationship was found between the M value and the rate of in vitro glucose oxidation.(ABSTRACT TRUNCATED AT 400 WORDS)
为评估1型糖尿病患者胰岛素抵抗的机制,我们检测了体内胰岛素敏感性及体外脂肪细胞的胰岛素作用。研究对象包括18例接受胰岛素治疗的1型糖尿病患者和14例匹配的正常受试者。对每位受试者采用正常血糖钳夹技术测定体内胰岛素介导的葡萄糖代谢清除率。对9例糖尿病患者和7例健康受试者进行开放性手术活检,获取腹部皮下脂肪组织,用于测定[125I]胰岛素结合、D-[14C]葡萄糖转运、氧化及脂肪生成。在正常血糖钳夹研究期间,两组维持相似的稳态血浆葡萄糖(4.8 mmol/L)和胰岛素(80 mU/L = 700 pM)水平。糖尿病患者的葡萄糖代谢率(M)(4.75±0.34 mg/kg·min)比正常受试者(8.27±0.43 mg/kg·min;P<0.001)低43%。糖尿病患者脂肪细胞的[125I]胰岛素结合减少(示踪剂结合减少26%;P<0.05),原因是受体数量减少。在任何胰岛素浓度下,胰岛素结合均与M值无关。糖尿病和正常受试者的基础及胰岛素刺激的葡萄糖转运率无显著差异。糖尿病患者的基础葡萄糖氧化率降低50%(P<0.02),最大葡萄糖氧化率降低49%(P<0.03)(基础与最大葡萄糖氧化分别为237±30 vs. 359±49 pmol/30,000细胞×90 min),而正常受试者为(513±101 vs. 700±133 pmol/30,000细胞×90 min)。两组葡萄糖氧化和葡萄糖转运对胰岛素的百分比反应相似。基础(r = 0.68;P<0.01)、半最大(ED50;r = 0.70;P<0.01)和最大(r = 0.64;P<0.05)有效胰岛素浓度下的葡萄糖氧化率与M值呈正相关。糖尿病和正常受试者的基础及胰岛素刺激的脂肪生成率相当。总之,常规治疗的1型糖尿病患者体内胰岛素介导的葡萄糖代谢清除率降低。体外实验中,糖尿病患者的脂肪细胞在示踪胰岛素浓度下结合的胰岛素略少,但这种减少幅度与体内葡萄糖代谢受损无关。在所研究的葡萄糖代谢途径中,葡萄糖氧化率受影响最大。发现M值与体外葡萄糖氧化率之间存在显著相关性。(摘要截选至400词)